• Mashup Score: 1

    However, there is a six-fold reduction in neutralizing titers in the B.1.351 variant from South Africa, so the company is exploring strategies aimed against new variants.

    Tweet Tweets with this article
    • #Moderna is advancing an emerging variant booster candidate, mRNA-1273.35, against the South African strain. The mRNA-1273.351 candidate will be going into preclinical studies and a phase 1 study in the US. #COVID19 #vaccine #VaccineforSouthAfrica https://t.co/opnoFN3KZQ